Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 134 | 115 | 873 | 1,846 | 15,289 |
| Gross Profit | 134 | 115 | 873 | 1,846 | 15,289 |
| Operating Expenses | 10,283 | 13,108 | 14,972 | 19,311 | 21,181 |
| Operating Income | -10,149 | -12,993 | -14,099 | -17,465 | -5,892 |
| Interest Expense | 716 | 834 | 439 | 502 | 581 |
| Other Income | -9 | -67 | 102 | 8 | 23 |
| Pre-tax Income | -10,874 | -13,894 | -14,436 | -17,959 | -6,450 |
| Net Income Continuous | -10,874 | -13,894 | -14,436 | -17,959 | -6,450 |
| Net Income | $-10,874 | $-13,894 | $-14,436 | $-17,959 | $-6,450 |
| EPS Basic Total Ops | -2.10 | -2.60 | -2.80 | -3.50 | -1.20 |
| EPS Basic Continuous Ops | -2.07 | -2.57 | -2.79 | -3.48 | -1.25 |
| EPS Diluted Total Ops | -2.10 | -2.60 | -2.80 | -3.50 | -1.20 |
| EPS Diluted Continuous Ops | -2.07 | -2.57 | -2.79 | -3.48 | -1.25 |
| EBITDA(a) | $-5,448 | $-9,535 | $-13,004 | $-16,536 | $-4,934 |